Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis
Condition: Facial Angiofibroma Interventions: Drug: Rapamycin; Drug: Calcitriol; Drug: Rapamycin-calcitriol combination Sponsor: National Taiwan University Hospital Completed - verified September 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Tuberous Sclerosis